Cargando…

Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia

T cell abnormalities have been reported to play an important role in pathogenesis of immune thrombocytopenia (ITP) besides specific autoantibodies towards platelet. The aim of this study was to explore the clinical importance of T lymphocyte subsets in adult patients with newly diagnosed ITP before...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhenhua, Yang, Lei, Yang, Guohua, Zhuang, Yun, Qian, Xifeng, Zhou, Xin, Xiao, Dajiang, Shen, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433177/ https://www.ncbi.nlm.nih.gov/pubmed/25978334 http://dx.doi.org/10.1371/journal.pone.0126601

Ejemplares similares

Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia
por: Zahran, Asmaa M., et al.
Publicado: (2017)

Platelet to Lymphocyte Ratio and Glucocorticoid Resistance in Newly Diagnosed Primary Immune Thrombocytopenia: A Retrospective Cohort Study
por: Wang, Lin-Hui, et al.
Publicado: (2019)

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
por: Grainger, John D., et al.
Publicado: (2021)

Adolescents and young adults with newly diagnosed primary immune thrombocytopenia
por: Schifferli, Alexandra, et al.
Publicado: (2023)

A case of newly diagnosed immune thrombocytopenia in the COVID-19 era
por: Clerici, Bianca, et al.
Publicado: (2020)

Doppler ultrasound screening in patients with newly diagnosed heparin-induced thrombocytopenia
por: Harris, Elyse I., et al.
Publicado: (2021)

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
por: Idogun, Precious O, et al.
Publicado: (2021)

Diagnostic Value of Peripheral Blood Lymphocytes for Primary Immune Thrombocytopenia
por: Lu, Jun, et al.
Publicado: (2022)

Hypovitaminosis D Influences the Clinical Presentation of Immune Thrombocytopenia in Children with Newly Diagnosed Disease
por: Petrovic, Davor, et al.
Publicado: (2019)

Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis
por: Wang, Yun, et al.
Publicado: (2022)

Abnormal Peripheral Neutrophil Transcriptome in Newly Diagnosed Type 2 Diabetes Patients
por: Lin, Qiuqiu, et al.
Publicado: (2020)

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Potentially Functional Polymorphism in IL-23 Receptor and Risk of Acute Myeloid Leukemia in a Chinese Population
por: Qian, Xifeng, et al.
Publicado: (2013)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
por: Ye, Fang, et al.
Publicado: (2021)

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
por: von Lukowicz, Hannah, et al.
Publicado: (2021)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020)

Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes
por: Tang, Xiaohan, et al.
Publicado: (2022)

Vitamin D abnormalities of children with recurrence of malignancy and comparison with newly diagnosed patients
por: Reisi, Nahid, et al.
Publicado: (2022)

Serum homocysteine level in newly diagnosed young patients with abnormal glucose tolerance
por: Rijal, Amrit, et al.
Publicado: (2023)

Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival
por: Zeng, Hui, et al.
Publicado: (2023)

Neutrophil to Lymphocyte Ratio Is Increased and Associated With Left Ventricular Diastolic Function in Newly Diagnosed Essential Hypertension Children
por: Hou, Miao, et al.
Publicado: (2021)

Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis
por: Arai, Yasuyuki, et al.
Publicado: (2018)

The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis
por: Xiao, Qirong, et al.
Publicado: (2021)

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
por: Snell Taylor, Sara J., et al.
Publicado: (2021)

Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia
por: Hamzah, Roszymah, et al.
Publicado: (2022)

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients
por: Wang, Li, et al.
Publicado: (2022)

Cardiac Abnormalities in Patients With Severe Fever With Thrombocytopenia Syndrome: A Systematic Review
por: Liu, Qiaoling, et al.
Publicado: (2023)

T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

Short-term dose-escalated romiplostim for preparing an adult patient with persistent newly diagnosed primary immune thrombocytopenia for splenectomy
por: Murray, Nigel P., et al.
Publicado: (2020)

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Severe Thrombocytopenia in a 30-Year-Old African American Male With Newly Diagnosed Sarcoidosis: A Case Report
por: Pasli, Melisa, et al.
Publicado: (2023)

Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis
por: Ren, Xiangge, et al.
Publicado: (2023)

Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
por: Shao, Xia, et al.
Publicado: (2018)

Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma
por: Tian, Ying, et al.
Publicado: (2018)

Newly developed thrombocytopenia in medical intensive care patients
por: Strauss, R, et al.
Publicado: (2000)

The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia
por: Guo, Xinhong, et al.
Publicado: (2015)

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
por: Savola, P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mqpe06d1nfnptqk04il8edhj1p